Healthcare Industry News:  Orthofix International 

Devices Orthopaedic Neurosurgery Personnel

 News Release - February 27, 2012

Orthofix International Announces New Executive to Lead Stimulation Business

LEWISVILLE, Texas--(Healthcare Sales & Marketing Network)--Orthofix International N.V., (NASDAQ:OFIX ) (the Company) announced today that it has hired Brad V. Niemann as Senior Vice President, Commercial Operations for the Global Spine business unit. In this position, Mr. Niemann will focus on managing the commercial operations of the Company’s Stimulation business. Mr. Niemann comes to Orthofix with over 14 years of experience and success in the industry.

“We are thrilled to announce the addition of Mr. Niemann to our management team,” said Robert Vaters, President and Chief Executive Officer. "With his leadership and expertise we will strengthen our ability to execute our business strategy of returning to growth in our regenerative stimulation business.”

About Orthofix:

Orthofix International N.V. is a diversified, global medical device company focused on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic markets. Orthofix’s products are widely distributed around the world to orthopedic surgeons and patients via Orthofix’s sales representatives and its subsidiaries, including BREG, Inc., and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, and Texas Scottish Rite Hospital for Children. For more information about Orthofix, please visit www.orthofix.com.


Source: Orthofix

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps 2 - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps 2 - available on the Apple App Store for iPhone and iPad.